Sentence examples for sensitization agent from inspiring English sources

In this work, the probability of Rhein to be a multi-target radiotherapy sensitization agent was explored through computer aid virtual screening by inverse docking study.

The improvement of biosynthesized AgNPs has allowed better control of shape and size more suitable for the increasing biomedical applications, such as implantable biomaterials, tumor radiotherapy sensitization agent, molecular imaging agents, biological markers, and drug delivery [20, 21].

Identification of EC patients candidate for chemotherapy with rs4430796 GG genotype could be useful in the clinical practice in the next future to schedule a different chemotherapy and/or the administration of a sensitization agent.

The development of multi-target radiotherapy sensitization agents offered a promising method for the treatment of NPC.

Based on the above data, Rhein is likely to become an attractive lead compound for the future design of multi-target radiotherapy sensitization agents.

Chemotherapeutic sensitization agents have been shown to alter the expression level of key apoptosis regulators in tumor cells [21], [43], [44], [45], [46], [47].

In cancer treatment, the role of mitochondrial apoptotic signaling in combination with other cellular events is already being translated to the clinic; drugs that target the Bcl-2 pathways are being tested as sensitization agents in combination with more traditional chemotherapy.

Since Bet v 1 is considered the main sensitizing agent in birch pollen showing a sensitization frequency of >95% [ 5], mice were immunized with Bet v 1 and thereafter treated with Bet v 1, BM4, or sham.

A number of insulin-sensitization agents have recently become available, but only metformin has been in use long enough for reliable conclusions to be drawn regarding its effects on cancer in vivo.

We conclude that genotoxicity data for an agent can provide indications of the agent's potential to induce skin sensitization and that genotoxins which are skin-sensitizing agents have an enhanced potential to initiate skin carcinogenesis.

APDC, YC-1 and MG-132 were confirmed as novel TRAIL sensitizing agents whilst the FDA-approved agent, Bortezomib, demonstrated caspase-8-dependent TRAIL-sensitization at 5 nM.